Grupo Aeroportuario del Pacífico (GAP) announced its Q2 2026 financial results, showing an 8.4% increase in EBITDA to Ps. 5,965.3 million, driven by the acquisition of full ownership of Cross Border Xpress (CBX) and a 3.7% rise in total revenues. Despite a 5.6% decline in passenger traffic across its 14 airports, GAP's operating income grew by 8.9%, supported by higher non-aeronautical revenues and cost management. The business combination with CBX, effective May 1, 2026, added significant assets and cash, positioning GAP for continued growth. The company revised its 2026 guidance, expecting up to 12% EBITDA growth and 7-10% total revenue increase.
FREELANDER, a British premium automotive brand co-developed by Chery and Jaguar Land Rover, announced its first international market launch in Abu Dhabi, UAE, scheduled for September 2026. This launch marks a key milestone in the brand's global expan...
The global blood glucose monitoring system market, valued at $16.8 billion in 2025, is projected to grow to $39.4 billion by 2035 at an 8.9% CAGR. Growth is fueled by rising diabetes prevalence, advancements in AI-enabled monitoring devices, and incr...
JCB, a Japanese payments company, has partnered with Circle to pilot the use of USDC, a dollar-backed stablecoin, for internal cross-border treasury transfers and merchant payments in Japan. The initial phase focuses on JCB's internal fund transfers,...
Pi Network's cryptocurrency PI plunged 17% on July 13 to an all-time low of $0.0785, driven by aggressive sell-offs from long-term holders known as "pioneers." The token has lost over 60% of its value year-to-date and 97% from its February 2025 peak ...
AstraZeneca has agreed to pay $600 million upfront, with up to $900 million more based on milestones, to acquire global rights to Zegfrovy, a lung cancer pill developed by China's Dizal Pharmaceutical. The drug targets non-small cell lung cancer pati...
